Josefin Ahnström/LinkedIn; Christina Crossette-Thambiah/ profiles.imperial.ac.uk
May 29, 2026, 04:37
Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
Josefin Ahnström, Associate Professor in Haematology at Imperial College London, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
”I am happy to share our most recent paper, published in Blood Advances, where we have investigated how Andexanet alfa impacts TFPI alpha function.
Amazing work Christina Crossette-Thambiah!
Thank you for all heart and hard work you’ve put into this project.”
Title: TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short
Authors: Christina Keshini Crossette-Thambiah, Krister Bamberg, Mike A Laffan, Josefin Ahnstrom
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology